Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
Abstract
:1. Introduction
2. Mesenchymal Stromal/Stem Cells and Radiotherapy
3. Radiation-Activated Mesenchymal Stromal/Stem Cells
4. Annexin A1 in the Inflammation and Hypoxia Processes Control
5. Annexin A1 in the Treatment of Inflammation
6. Annexin A1 and Lung Diseases
7. COVID-19: The Magnitude of the Problem
8. Clinical Trials of MSCs Transplantation in Patients with COVID-19 Pneumonia
9. Conclusions and Perspectives
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Keating, A. Mesenchymal stromal cells: New directions. Cell Stem Cell 2012, 10, 709–716. [Google Scholar] [CrossRef] [Green Version]
- Squillaro, T.; Peluso, G.; Galderisi, U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2016, 25, 829–848. [Google Scholar] [CrossRef] [Green Version]
- Farias, V.A.; Linares-Fernandez, J.L.; Penalver, J.L.; Paya Colmenero, J.A.; Ferron, G.O.; Duran, E.L.; Fernandez, R.M.; Olivares, E.G.; O’Valle, F.; Puertas, A.; et al. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta 2011, 32, 86–95. [Google Scholar] [CrossRef]
- Peñalver, J.L.; Linares-Fernández, J.L.; de Araujo Farías, V.; López-Ramón, M.V.; Tassi, M.; Oliver, F.J.; Moreno-Castilla, C.; deAlmodóvar, J.M.R. Activated carbon cloth as support for mesenchymal stem cell growth and differentiation to osteocyte. Carbon 2009, 47, 3574–3577. [Google Scholar] [CrossRef]
- de Araújo Farias, V.; López-Peñalver, J.J.; Sirés-Campos, J.; López-Ramón, M.V.; Moreno-Castilla, C.; Oliver, F.J.; de Almodóvar, J.M.R. Growth and spontaneous differentiation of umbilical-cord stromal stem cells on activated carbon cloth. J. Mater. Chem. B 2013, 1, 3359–3368. [Google Scholar] [CrossRef]
- Gomez-Millan, J.; Katz, I.S.; Farias Vde, A.; Linares-Fernandez, J.L.; Lopez-Penalver, J.; Ortiz-Ferron, G.; Ruiz-Ruiz, C.; Oliver, F.J.; Ruiz de Almodovar, J.M. The importance of bystander effects in radiation therapy in melanoma skin-cancer cells and umbilical-cord stromal stem cells. Radiother. Oncol. 2012, 102, 450–458. [Google Scholar] [CrossRef]
- De Araujo Farias, V.; O’Valle, F.; Lerma, B.A.; Ruiz de Almodovar, C.; Lopez-Penalver, J.J.; Nieto, A.; Santos, A.; Fernandez, B.I.; Guerra-Librero, A.; Ruiz-Ruiz, M.C.; et al. Human mesenchymal stem cells enhance the systemic effects of radiotherapy. Oncotarget 2015, 6, 31164–31180. [Google Scholar] [CrossRef] [Green Version]
- de Araujo Farias, V.; O’Valle, F.; Serrano-Saenz, S.; Anderson, P.; Andres, E.; Lopez-Penalver, J.; Tovar, I.; Nieto, A.; Santos, A.; Martin, F.; et al. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci. Mol. Cancer 2018, 17, 122. [Google Scholar] [CrossRef] [PubMed]
- Lara, P.C.; Lopez-Penalver, J.J.; Farias Vde, A.; Ruiz-Ruiz, M.C.; Oliver, F.J.; Ruiz de Almodovar, J.M. Direct and bystander radiation effects: A biophysical model and clinical perspectives. Cancer Lett. 2015, 356, 5–16. [Google Scholar] [CrossRef]
- Mothersill, C.E.; Moriarty, M.J.; Seymour, C.B. Radiotherapy and the potential exploitation of bystander effects. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58, 575–579. [Google Scholar] [CrossRef]
- Formenti, S.C.; Demaria, S. Systemic effects of local radiotherapy. Lancet Oncol. 2009, 10, 718–726. [Google Scholar] [CrossRef] [Green Version]
- Farias, V.A.; Tovar, I.; Del Moral, R.; O’Valle, F.; Exposito, J.; Oliver, F.J.; Ruiz de Almodovar, J.M. Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes. Front. Oncol. 2019, 9, 1381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Decrock, E.; Hoorelbeke, D.; Ramadan, R.; Delvaeye, T.; De Bock, M.; Wang, N.; Krysko, D.V.; Baatout, S.; Bultynck, G.; Aerts, A.; et al. Calcium, oxidative stress and connexin channels, a harmonious orchestra directing the response to radiotherapy treatment? BBA Mol. Cell. Res. 2017, 1864, 1099–1120. [Google Scholar] [CrossRef] [PubMed]
- Azzam, E.I.; de Toledo, S.M.; Little, J.B. Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene 2003, 22, 7050–7057. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, S.M.; Oh, J.H.; Park, S.A.; Ryu, C.H.; Lim, J.Y.; Kim, D.S.; Chang, J.W.; Oh, W.; Jeun, S.S. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem cells 2010, 28, 2217–2228. [Google Scholar] [CrossRef]
- Mothersill, C.; Seymour, C.B. Radiation-induced bystander effects--implications for cancer. Nat. Rev. Cancer 2004, 4, 158–164. [Google Scholar] [CrossRef]
- Prise, K.M.; Schettino, G.; Folkard, M.; Held, K.D. New insights on cell death from radiation exposure. Lancet Oncol. 2005, 6, 520–528. [Google Scholar] [CrossRef]
- Formenti, S.C.; Demaria, S.; Barcellos-Hoff, M.H.; McBride, W.H. Subverting misconceptions about radiation therapy. Nat. Immunol. 2016, 17, 345. [Google Scholar] [CrossRef]
- Golden, E.B.; Apetoh, L. Radiotherapy and immunogenic cell death. Semin. Radiat. Oncol. 2015, 25, 11–17. [Google Scholar] [CrossRef] [Green Version]
- Golden, E.B.; Formenti, S.C. Radiation therapy and immunotherapy: Growing pains. Int. J. Radiat. Oncol. Biol. Phys. 2015, 91, 252–254. [Google Scholar] [CrossRef]
- Petroni, G.; Formenti, S.C.; Chen-Kiang, S.; Galluzzi, L. Immunomodulation by anticancer cell cycle inhibitors. Nat. Rev. Immunol. 2020. [Google Scholar] [CrossRef]
- Demaria, S.; Formenti, S.C. The abscopal effect 67 years later: From a side story to center stage. Br. J. Radiol. 2020, 93. [Google Scholar] [CrossRef] [PubMed]
- Chang, P.Y.; Qu, Y.Q.; Wang, J.; Dong, L.H. The potential of mesenchymal stem cells in the management of radiation enteropathy. Cell Death Dis. 2015, 6, e1840. [Google Scholar] [CrossRef] [Green Version]
- Maziarz, R.T.; Devos, T.; Bachier, C.R.; Goldstein, S.C.; Leis, J.F.; Devine, S.M.; Meyers, G.; Gajewski, J.L.; Maertens, J.; Deans, R.J.; et al. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: A phase 1 trial. Biol. Blood Marrow Transplant. 2015, 21, 720–728. [Google Scholar] [CrossRef] [Green Version]
- Klein, D.; Schmetter, A.; Imsak, R.; Wirsdorfer, F.; Unger, K.; Jastrow, H.; Stuschke, M.; Jendrossek, V. Therapy with Multipotent Mesenchymal Stromal Cells Protects Lungs from Radiation-Induced Injury and Reduces the Risk of Lung Metastasis. Antioxid. Redox Signal 2016, 24, 53–69. [Google Scholar] [CrossRef] [Green Version]
- Bernardo, M.E.; Cometa, A.M.; Locatelli, F. Mesenchymal stromal cells: A novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? Bone Marrow Transplant. 2012, 47, 323–329. [Google Scholar] [CrossRef] [Green Version]
- Nicolay, N.H.; Liang, Y.; Lopez Perez, R.; Bostel, T.; Trinh, T.; Sisombath, S.; Weber, K.J.; Ho, A.D.; Debus, J.; Saffrich, R.; et al. Mesenchymal stem cells are resistant to carbon ion radiotherapy. Oncotarget 2015, 6, 2076–2087. [Google Scholar] [CrossRef]
- Loebinger, M.R.; Sage, E.K.; Davies, D.; Janes, S.M. TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population. Br. J. Cancer 2010, 103, 1692–1697. [Google Scholar] [CrossRef]
- Loebinger, M.R.; Janes, S.M. Stem cells as vectors for antitumour therapy. Thorax 2010, 65, 362–369. [Google Scholar] [CrossRef] [Green Version]
- Nicolay, N.H.; Lopez Perez, R.; Debus, J.; Huber, P.E. Mesenchymal stem cells—A new hope for radiotherapy-induced tissue damage? Cancer Lett. 2015, 366, 133–140. [Google Scholar] [CrossRef]
- Skripcak, T.; Belka, C.; Bosch, W.; Brink, C.; Brunner, T.; Budach, V.; Buttner, D.; Debus, J.; Dekker, A.; Grau, C.; et al. Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets. Radiother. Oncol. 2014, 113, 303–309. [Google Scholar] [CrossRef] [PubMed]
- Murphy, M.B.; Moncivais, K.; Caplan, A.I. Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 2013, 45, e54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, R.H.; Yoon, N.; Reneau, J.C.; Prockop, D.J. Preactivation of human MSCs with TNF-alpha enhances tumor-suppressive activity. Cell Stem Cell 2012, 11, 825–835. [Google Scholar] [CrossRef] [Green Version]
- Ozcan, S.; Alessio, N.; Acar, M.B.; Mert, E.; Omerli, F.; Peluso, G.; Galderisi, U. Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses. Aging 2016, 8, 1316–1329. [Google Scholar] [CrossRef] [Green Version]
- O’Malley, G.; Heijltjes, M.; Houston, A.M.; Rani, S.; Ritter, T.; Egan, L.J.; Ryan, A.E. Mesenchymal stromal cells (MSCs) and colorectal cancer: A troublesome twosome for the anti-tumour immune response? Oncotarget 2016, 7, 60752–60774. [Google Scholar] [CrossRef] [Green Version]
- Hass, R.; von der Ohe, J.; Ungefroren, H. Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation. Cancers 2019, 11, 1432. [Google Scholar] [CrossRef] [Green Version]
- Shi, Y.; Du, L.; Lin, L.; Wang, Y. Tumour-associated mesenchymal stem/stromal cells: Emerging therapeutic targets. Nat. Rev. Drug Discov. 2017, 16, 35–52. [Google Scholar] [CrossRef]
- Chowdhury, R.; Webber, J.P.; Gurney, M.; Mason, M.D.; Tabi, Z.; Clayton, A. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget 2015, 6, 715–731. [Google Scholar] [CrossRef]
- Wu, S.; Ju, G.Q.; Du, T.; Zhu, Y.J.; Liu, G.H. Microvesicles derived from human umbilical cord Wharton’s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS ONE 2013, 8, e61366. [Google Scholar] [CrossRef]
- Vieira de Castro, J.; Gomes, E.D.; Granja, S.; Anjo, S.I.; Baltazar, F.; Manadas, B.; Salgado, A.J.; Costa, B.M. Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology. J. Transl. Med. 2017, 15. [Google Scholar] [CrossRef]
- Yun, W.S.; Aryal, S.; Ahn, Y.J.; Seo, Y.J.; Key, J. Engineered iron oxide nanoparticles to improve regenerative effects of mesenchymal stem cells. Biomed. Eng. Lett. 2020, 10, 259–273. [Google Scholar] [CrossRef]
- Liu, Z.; Mikrani, R.; Zubair, H.M.; Taleb, A.; Naveed, M.; Baig, M.; Zhang, Q.; Li, C.; Habib, M.; Cui, X.; et al. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations. Eur. J. Pharmacol. 2020, 876. [Google Scholar] [CrossRef]
- Nitzsche, F.; Muller, C.; Lukomska, B.; Jolkkonen, J.; Deten, A.; Boltze, J. Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. Stem Cells 2017, 35, 1446–1460. [Google Scholar] [CrossRef] [Green Version]
- Harrell, C.R.; Jovicic, N.; Djonov, V.; Arsenijevic, N.; Volarevic, V. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells 2019, 8, 1605. [Google Scholar] [CrossRef] [Green Version]
- Carreras-Planella, L.; Monguio-Tortajada, M.; Borras, F.E.; Franquesa, M. Immunomodulatory Effect of MSC on B Cells Is Independent of Secreted Extracellular Vesicles. Front. Immunol. 2019, 10. [Google Scholar] [CrossRef] [Green Version]
- Moussa, L.; Pattappa, G.; Doix, B.; Benselama, S.L.; Demarquay, C.; Benderitter, M.; Semont, A.; Tamarat, R.; Guicheux, J.; Weiss, P.; et al. A biomaterial-assisted mesenchymal stromal cell therapy alleviates colonic radiation-induced damage. Biomaterials 2017, 115, 40–52. [Google Scholar] [CrossRef] [Green Version]
- Lee, R.H.; Pulin, A.A.; Seo, M.J.; Kota, D.J.; Ylostalo, J.; Larson, B.L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5, 54–63. [Google Scholar] [CrossRef] [Green Version]
- Hu, S.; Park, J.; Liu, A.; Lee, J.; Zhang, X.; Hao, Q.; Lee, J.W. Mesenchymal Stem Cell Microvesicles Restore Protein Permeability Across Primary Cultures of Injured Human Lung Microvascular Endothelial Cells. Stem Cells Transl. Med. 2018, 7, 615–624. [Google Scholar] [CrossRef]
- Rager, T.M.; Olson, J.K.; Zhou, Y.; Wang, Y.; Besner, G.E. Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis. J. Pediatr. Surg. 2016, 51, 942–947. [Google Scholar] [CrossRef] [Green Version]
- Bessout, R.; Demarquay, C.; Moussa, L.; Rene, A.; Doix, B.; Benderitter, M.; Semont, A.; Mathieu, N. TH17 predominant T-cell responses in radiation-induced bowel disease are modulated by treatment with adipose-derived mesenchymal stromal cells. J. Pathol. 2015, 237, 435–446. [Google Scholar] [CrossRef]
- Van de Putte, D.; Demarquay, C.; Van Daele, E.; Moussa, L.; Vanhove, C.; Benderitter, M.; Ceelen, W.; Pattyn, P.; Mathieu, N. Adipose-Derived Mesenchymal Stromal Cells Improve the Healing of Colonic Anastomoses Following High Dose of Irradiation Through Anti-Inflammatory and Angiogenic Processes. Cell Transplant. 2017, 26, 1919–1930. [Google Scholar] [CrossRef] [PubMed]
- Lopez, E.; Guerrero, R.; Nunez, M.I.; del Moral, R.; Villalobos, M.; Martinez-Galan, J.; Valenzuela, M.T.; Munoz-Gamez, J.A.; Oliver, F.J.; Martin-Oliva, D.; et al. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. Breast. Cancer Res. 2005, 7, R690–R698. [Google Scholar] [CrossRef] [PubMed]
- Weyd, H. More than just innate affairs—On the role of annexins in adaptive immunity. J. Biol. Chem. 2016, 397, 1017–1029. [Google Scholar] [CrossRef] [PubMed]
- Guo, C.; Liu, S.; Sun, M.Z. Potential role of Anxa1 in cancer. Future Oncol. 2013, 9, 1773–1793. [Google Scholar] [CrossRef] [PubMed]
- Boudhraa, Z.; Bouchon, B.; Viallard, C.; D’Incan, M.; Degoul, F. Annexin A1 localization and its relevance to cancer. Clin. Sci. 2016, 130, 205–220. [Google Scholar] [CrossRef]
- Alessandri, A.L.; Sousa, L.P.; Lucas, C.D.; Rossi, A.G.; Pinho, V.; Teixeira, M.M. Resolution of inflammation: Mechanisms and opportunity for drug development. Pharmacol. Ther. 2013, 139, 189–212. [Google Scholar] [CrossRef] [Green Version]
- Soehnlein, O.; Lindbom, L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010, 10, 427–439. [Google Scholar] [CrossRef]
- Fredman, G.; Tabas, I. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. Am. J. Pathol. 2017, 187, 1211–1221. [Google Scholar] [CrossRef] [Green Version]
- Ansari, J.; Kaur, G.; Gavins, F.N.E. Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury. Int. J. Mol. Sci. 2018, 19, 1211. [Google Scholar] [CrossRef] [Green Version]
- Shalapour, S.; Karin, M. Immunity, inflammation, and cancer: An eternal fight between good and evil. J. Clin. Investig. 2015, 125, 3347–3355. [Google Scholar] [CrossRef] [Green Version]
- Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The Next Generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shen, Y.; Wang, X.; Lu, J.; Salfenmoser, M.; Wirsik, N.M.; Schleussner, N.; Imle, A.; Freire Valls, A.; Radhakrishnan, P.; Liang, J.; et al. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. Cancer Cell 2020, 37, 800–817. [Google Scholar] [CrossRef] [PubMed]
- Sheikh, M.H.; Solito, E. Annexin A1: Uncovering the Many Talents of an Old Protein. Int. J. Mol. Sci. 2018, 19, 1045. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leoni, G.; Nusrat, A. Annexin A1: Shifting the balance towards resolution and repair. J. Biol. Chem. 2016, 397, 971–979. [Google Scholar] [CrossRef] [PubMed]
- Galvao, I.; de Carvalho, R.V.H.; Vago, J.P.; Silva, A.L.N.; Carvalho, T.G.; Antunes, M.M.; Ribeiro, F.M.; Menezes, G.B.; Zamboni, D.S.; Sousa, L.P.; et al. The role of annexin A1 in the modulation of the NLRP3 inflammasome. Immunology 2020, 160, 78–89. [Google Scholar] [CrossRef] [PubMed]
- Trentin, P.G.; Ferreira, T.P.; Arantes, A.C.; Ciambarella, B.T.; Cordeiro, R.S.; Flower, R.J.; Perretti, M.; Martins, M.A.; Silva, P.M. Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice. Br. J. Pharmacol. 2015, 172, 3058–3071. [Google Scholar] [CrossRef] [Green Version]
- Sun, Z.; Shi, K.; Yang, S.; Liu, J.; Zhou, Q.; Wang, G.; Song, J.; Li, Z.; Zhang, Z.; Yuan, W. Effect of exosomal miRNA on cancer biology and clinical applications. Mol. Cancer 2018, 17. [Google Scholar] [CrossRef]
- Ma, Q.; Zhang, Z.; Shim, J.K.; Venkatraman, T.N.; Lascola, C.D.; Quinones, Q.J.; Mathew, J.P.; Terrando, N.; Podgoreanu, M.V. Annexin A1 Bioactive Peptide Promotes Resolution of Neuroinflammation in a Rat Model of Exsanguinating Cardiac Arrest Treated by Emergency Preservation and Resuscitation. Front. Neurosci. 2019, 13. [Google Scholar] [CrossRef] [Green Version]
- Purvis, G.S.D.; Solito, E.; Thiemermann, C. Annexin-A1: Therapeutic Potential in Microvascular Disease. Front. Immunol. 2019, 10. [Google Scholar] [CrossRef] [Green Version]
- Purvis, G.S.D.; Collino, M.; Loiola, R.A.; Baragetti, A.; Chiazza, F.; Brovelli, M.; Sheikh, M.H.; Collotta, D.; Cento, A.; Mastrocola, R.; et al. Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. Front. Immunol. 2019, 10. [Google Scholar] [CrossRef] [Green Version]
- Damazo, A.S.; Sampaio, A.L.; Nakata, C.M.; Flower, R.J.; Perretti, M.; Oliani, S.M. Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis. BMC Immunol. 2011, 12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Corminboeuf, O.; Leroy, X. FPR2/ALXR agonists and the resolution of inflammation. J. Med. Chem. 2015, 58, 537–559. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Yan, S.F.; Hao, Y.; Jin, S.W. Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. Chin. Med. J. 2018, 131, 982–989. [Google Scholar] [CrossRef] [PubMed]
- Sznajder, J.I. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am. J. Respir. Crit. Care Med. 2001, 163, 1293–1294. [Google Scholar] [CrossRef] [PubMed]
- Da Cunha, E.E.; Oliani, S.M.; Damazo, A.S. Effect of annexin-A1 peptide treatment during lung inflammation induced by lipopolysaccharide. Pulm Pharmacol. Ther. 2012, 25, 303–311. [Google Scholar] [CrossRef]
- Han, G.; Lu, K.; Xu, W.; Zhang, S.; Huang, J.; Dai, C.; Sun, G.; Ye, J. Annexin A1-mediated inhibition of inflammatory cytokines may facilitate the resolution of inflammation in acute radiation-induced lung injury. Oncol. Lett. 2019, 18, 321–329. [Google Scholar] [CrossRef]
- Machado, M.G.; Tavares, L.P.; Souza, G.V.S.; Queiroz-Junior, C.M.; Ascencao, F.R.; Lopes, M.E.; Garcia, C.C.; Menezes, G.B.; Perretti, M.; Russo, R.C.; et al. The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia. FASEB J. 2020, 34, 2749–2764. [Google Scholar] [CrossRef] [Green Version]
- Leng, Z.; Zhu, R.; Hou, W.; Feng, Y.; Yang, Y.; Han, Q.; Shan, G.; Meng, F.; Du, D.; Wang, S.; et al. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020, 11, 216–228. [Google Scholar] [CrossRef] [Green Version]
- McIntyre, L.A.; Stewart, D.J.; Mei, S.H.J.; Courtman, D.; Watpool, I.; Granton, J.; Marshall, J.; Dos Santos, C.; Walley, K.R.; Winston, B.W.; et al. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial. Am. J. Respir. Crit. Care Med. 2018, 197, 337–347. [Google Scholar] [CrossRef]
- Nolta, J.A.; Galipeau, J.; Phinney, D.G. Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congres de Montreal, Organized by the ISCT MSC Scientific Committee. Cytotherapy 2020, 22, 123–126. [Google Scholar] [CrossRef]
- Atluri, S.; Manchikanti, L.; Hirsch, J.A. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Pain Physician 2020, 23, E71–E83. [Google Scholar] [PubMed]
- Wu, Z.; McGoogan, J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020. [Google Scholar] [CrossRef] [PubMed]
- Golchin, A.; Seyedjafari, E.; Ardeshirylajimi, A. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. Stem Cell Rev. 2020. [Google Scholar] [CrossRef] [Green Version]
- Moll, G.; Drzeniek, N.; Kamhieh-Milz, J.; Geissler, S.; Volk, H.D.; Reinke, P. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front. Immunol. 2020, 11. [Google Scholar] [CrossRef]
- Zhu, F.C.; Li, Y.H.; Guan, X.H.; Hou, L.H.; Wang, W.J.; Li, J.X.; Wu, S.P.; Wang, B.S.; Wang, Z.; Wang, L.; et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020, 395, 1845–1854. [Google Scholar] [CrossRef]
- Corey, L.; Mascola, J.R.; Fauci, A.S.; Collins, F.S. A strategic approach to COVID-19 vaccine R&D. Science 2020, 368, 948–950. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tovar, I.; Guerrero, R.; López-Peñalver, J.J.; Expósito, J.; Ruiz de Almodóvar, J.M. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome. Cells 2020, 9, 2015. https://doi.org/10.3390/cells9092015
Tovar I, Guerrero R, López-Peñalver JJ, Expósito J, Ruiz de Almodóvar JM. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome. Cells. 2020; 9(9):2015. https://doi.org/10.3390/cells9092015
Chicago/Turabian StyleTovar, Isabel, Rosa Guerrero, Jesús J. López-Peñalver, José Expósito, and José Mariano Ruiz de Almodóvar. 2020. "Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome" Cells 9, no. 9: 2015. https://doi.org/10.3390/cells9092015